Key result
Lipid profile components predict ~10 percentage points more total cholesterol variance in heart disease patients.
Why the study?
Dyslipidemia is a major modifiable risk factor for CVD, but the lipid components most strongly associated with elevated total cholesterol in heart disease versus non-heart patients in Pakistan were not well characterized.
Cross-Sectional (n=180)
Yes
Lipid components, particularly LDL and VLDL, more strongly dictate total cholesterol variance in heart disease patients compared to non-heart patients, underscoring differing metabolic behaviors between the populations.
May inform LDL-focused lipid monitoring in heart disease; leaves open causal and therapeutic implications pending prospective data.
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, with a rapidly increasing burden in low- and middle-income countries such as Pakistan. Dyslipidemia is a major modifiable risk factor for CVD and plays a crucial role in the development and progression of atherosclerosis. This study aimed to compare lipid profile parameters between heart disease patients and non-heart individuals and to identify lipid components most strongly associated with elevated total cholesterol in District Sargodha. A cross-sectional analytical study was conducted using secondary data collected from public and private hospitals and diagnostic laboratories in Sargodha. A total of 180 lipid profile reports were included, comprising heart disease patients with confirmed cardiovascular conditions and non-heart individuals with no documented history of CVD. Data on total cholesterol, LDL, HDL, triglycerides, and VLDL were analyzed using SPSS. Descriptive statistics, independent sample t-tests, Pearson correlation, and multiple linear regression analyses were applied to assess associations and predictors. The regression model for heart disease patients was highly significant and explained 99.7% of the variance in total cholesterol levels. LDL cholesterol emerged as the strongest predictor, followed by triglycerides, HDL, and VLDL. In non-heart patients, the model explained 90.3% of cholesterol variability, with LDL, HDL, and triglycerides as significant predictors, while VLDL showed no significant association. In conclusion, lipid abnormalities—particularly elevated LDL cholesterol—are strongly associated with total cholesterol levels, with a more pronounced effect among heart disease patients. These findings emphasize the importance of early lipid screening and targeted cholesterol management to reduce cardiovascular risk in the population.
No takes yet. Share an insight, caveat, or question.
Fatima et al. (2025) conducted a cross-sectional in Cardiovascular disease (n=180). Cardiovascular disease vs. No documented history of cardiovascular disease was evaluated on Variance in total cholesterol levels explained by lipid profile components (R-squared percentage) (p=<0.001). Lipid profile components, particularly LDL cholesterol, strongly predicted total cholesterol levels, explaining 99.7% of the variance in heart disease patients compared to 90.3% in non-heart patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: